PMC:7105881 / 24269-24460 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T98","span":{"begin":150,"end":158},"obj":"Body_part"}],"attributes":[{"id":"A98","pred":"fma_id","subj":"T98","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"ce immune responses and/or neutralizing antibodies, NTD and S2 as the targets of subunit vaccines are less immunogenic, eliciting significantly lower antibody titers, cellular immune response"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T102","span":{"begin":52,"end":55},"obj":"Disease"}],"attributes":[{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0008449"},{"id":"A103","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0018075"}],"text":"ce immune responses and/or neutralizing antibodies, NTD and S2 as the targets of subunit vaccines are less immunogenic, eliciting significantly lower antibody titers, cellular immune response"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T253","span":{"begin":60,"end":62},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T254","span":{"begin":60,"end":62},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"}],"text":"ce immune responses and/or neutralizing antibodies, NTD and S2 as the targets of subunit vaccines are less immunogenic, eliciting significantly lower antibody titers, cellular immune response"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T103","span":{"begin":60,"end":62},"obj":"Chemical"}],"attributes":[{"id":"A103","pred":"chebi_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"}],"text":"ce immune responses and/or neutralizing antibodies, NTD and S2 as the targets of subunit vaccines are less immunogenic, eliciting significantly lower antibody titers, cellular immune response"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T38","span":{"begin":3,"end":19},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ce immune responses and/or neutralizing antibodies, NTD and S2 as the targets of subunit vaccines are less immunogenic, eliciting significantly lower antibody titers, cellular immune response"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T459","span":{"begin":3,"end":9},"obj":"UBERON:0002405;GO:0006955"},{"id":"T460","span":{"begin":10,"end":19},"obj":"GO:0006955"},{"id":"T461","span":{"begin":40,"end":50},"obj":"GO:0042571"},{"id":"T462","span":{"begin":107,"end":118},"obj":"CHEBI:60816;CHEBI:60816"},{"id":"T463","span":{"begin":150,"end":158},"obj":"GO:0042571"},{"id":"T464","span":{"begin":167,"end":175},"obj":"GO:0006955"},{"id":"T465","span":{"begin":176,"end":182},"obj":"GO:0006955;UBERON:0002405"},{"id":"T22583","span":{"begin":3,"end":9},"obj":"UBERON:0002405;GO:0006955"},{"id":"T14806","span":{"begin":10,"end":19},"obj":"GO:0006955"},{"id":"T85003","span":{"begin":40,"end":50},"obj":"GO:0042571"},{"id":"T22299","span":{"begin":107,"end":118},"obj":"CHEBI:60816;CHEBI:60816"},{"id":"T45192","span":{"begin":150,"end":158},"obj":"GO:0042571"},{"id":"T10184","span":{"begin":167,"end":175},"obj":"GO:0006955"},{"id":"T61855","span":{"begin":176,"end":182},"obj":"GO:0006955;UBERON:0002405"}],"text":"ce immune responses and/or neutralizing antibodies, NTD and S2 as the targets of subunit vaccines are less immunogenic, eliciting significantly lower antibody titers, cellular immune response"}